Target intelligence / Profile preview

NADPH oxidase 4 mRNA 3' untranslated region (NOX4 mRNA 3'UTR) (NOX4 mRNA 3'UTR)

Target
NOX4 mRNA 3'UTR
Molecular classification
RNA, mRNA regulatory element, Untranslated region
01

Overview

The NADPH oxidase 4 (NOX4) mRNA 3' untranslated region (3'UTR) is a critical regulatory segment of the NOX4 transcript that governs the stability and translation of the NOX4 enzyme. Unlike other NOX isoforms, NOX4 is constitutively active and primarily regulated at the transcriptional and post-transcriptional levels, making its mRNA 3'UTR a key site for controlling cellular reactive oxygen species (ROS) production [PMID: 22319247]. This region contains multiple conserved binding sites for microRNAs, such as miR-25 and miR-146a, which act as endogenous suppressors of NOX4 expression to maintain redox homeostasis [PMID: 23912945, PMID: 28652424]. In pathological states like idiopathic pulmonary fibrosis and diabetic nephropathy, the regulation of the NOX4 3'UTR is often disrupted, leading to enzyme overexpression, excessive hydrogen peroxide production, and subsequent tissue damage and fibrosis [PMID: 25100643]. Targeting the NOX4 mRNA 3'UTR with antisense oligonucleotides or microRNA mimics represents a precise therapeutic strategy to downregulate NOX4 protein levels and mitigate oxidative stress-driven diseases. Such approaches aim to overcome the limitations of small-molecule inhibitors by providing higher specificity for the NOX4 isoform over other NADPH oxidases.

Other names
NOX4 3' untranslated regionNADPH oxidase 4 3'UTRRENOX mRNA 3'UTRNOX4 3-prime UTR
02

Mechanism of action

Therapeutic agents target the NOX4 mRNA 3'UTR to modulate protein expression through RNA interference (RNAi), antisense-mediated degradation (RNase H recruitment), or by blocking/mimicking microRNA binding sites to alter mRNA stability and translation.

03

Biological functions

Regulation of mRNA stabilityTranslation regulationReactive oxygen species production regulationOxidative stress responseCellular senescence
04

Disease associations

Idiopathic pulmonary fibrosisDiabetic nephropathyCardiovascular diseaseLiver fibrosisCancerAtherosclerosis
05

Safety considerations

Off-target hybridization effectsPotential disruption of physiological ROS signaling required for host defenseTissue-specific delivery challengesPotential for unintended immune activation by synthetic oligonucleotides
06

Interacting drugs

miR-25 mimic

2 more in the full profile.

07

Biomarkers

NOX4 mRNA expression levelsHydrogen peroxide (H2O2) concentrationAlpha-smooth muscle actin (α-SMA) expression8-hydroxy-2'-deoxyguanosine (8-OHdG)

Beyond the preview

Go deeper on NADPH oxidase 4 mRNA 3' untranslated region (NOX4 mRNA 3'UTR) (NOX4 mRNA 3'UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADPH oxidase 4 mRNA 3' untranslated region (NOX4 mRNA 3'UTR) (NOX4 mRNA 3'UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call